Date |
Inspection Type |
Inspection ID |
Inspection Result |
|
May 2, 2025 |
Monitoring |
2025-I-YRO-037049
|
No violations cited for this Inspection |
|
Feb 26, 2025 |
Annual Unannounced |
2025-I-YRO-001458
|
Violations Found
|
|
|
|
|
Regulation |
Description |
Compliance Status |
417.15(c)(6) |
The program must maintain on file at the family day care home, available for inspection by the Office or its designees at any time, the following records in a current and accurate manner: children's individual health care plans; parental consents for emergency medical treatment; child's medical statement, immunizations, and any available results of lead screening for children not yet enrolled in kindergarten or a higher grade only; the name and dosage of any medications used by a child, the frequency of administration of such medications, and a record of their administration by caregivers; daily health check documentation; a record of illnesses and injuries occurring while in care; and any indicators of child abuse or maltreatment; |
Corrected |
|
Oct 25, 2024 |
Monitoring |
2024-I-YRO-103342
|
Violations Found
|
|
|
|
|
Regulation |
Description |
Compliance Status |
417.5(i) |
Protective caps, covers or permanently installed obstructive devices must be used on all electrical outlets that are accessible to children. |
Corrected |
417.11(f)(7) |
Permissions needed from parent and/or health care provider in order to administer medications: |
Corrected |
|
Aug 23, 2024 |
Monitoring |
2024-I-YRO-079929
|
No violations cited for this Inspection |
|
Jun 6, 2024 |
Monitoring |
2024-I-YRO-049927
|
No violations cited for this Inspection |
|
Feb 5, 2024 |
Annual Unannounced |
2024-I-YRO-001042
|
Violations Found
|
|
|
|
|
Regulation |
Description |
Compliance Status |
417.11(f)(1)(i) |
All programs that choose to administer medications other than epinephrine auto injectors, diphenhydramine in combination with the auto injector, asthma inhalers and nebulizers, topical ointments, lotions, creams and sprays to children must have a health care consultant of record and must address the administration of medications in the health care plan in accordance with the requirements of section 417.11 of this Part. |
Corrected |
|